Simulated value-based insurance design applied to statin use by medicare beneficiaries with diabetes

Value in Health

Volumn 15, Issue 3, 2012, Pages 404-411

  Davidoff, Amy ^a   Lopert, Ruth ^b   Stuart, Bruce ^a   Shaffer, Thomas ^a   Lloyd, Jennifer T ^a   Shoemaker, J Samantha ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

cost offsets; diabetes; Medicare; medication adherence

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; COST; COST CONTROL; DIABETES MELLITUS; DRUG COST; FEMALE; HEALTH INSURANCE; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRESCRIPTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SELF REPORT; VALUE BASED INSURANCE;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FINANCING, PERSONAL; HEALTH CARE SURVEYS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INSURANCE COVERAGE; INSURANCE, HEALTH; MALE; MEDICARE; MIDDLE AGED; PATIENT COMPLIANCE; PROGRAM DEVELOPMENT; QUALITY OF HEALTH CARE; REGRESSION ANALYSIS; UNITED STATES;

EID: 84861168917     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2012.01.008     Document Type: Article

References (47)

1. A.M. Fendrick, D.G. Smith, M.E. Chernew, S.N. Shah A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost Am J Manag Care 7 2001 861 867 (Pubitemid 32904146)
2. M.E. Chernew, A.B. Rosen, A.M. Fendrick Value-based insurance design Health Aff (Millwood) 26 2007 w195 w203
3. A. Giuffrida, H. Gravelle Paying patients to comply: an economic analysis Health Econ 7 1998 569 579 (Pubitemid 28521896)
4. A.F. Brown, C.M. Mangione, D. Saliba Guidelines for improving the care of the older person with diabetes mellitus J Am Geriatr Soc 51 Suppl. 2003 S265 S280
5. P.S. Odegard, K. Capoccia Medication taking and diabetes: a systematic review of the literature Diabetes Educ 33 2007 1014 1029 discussion 1030-1
6. American Diabetes Association Standards of medical care in diabetes - 2010 Diabetes Care 33 Suppl. 1 2010 S11 S61
7. Y. Kamari, R. Bitzur, H. Cohen Should all diabetic patients be treated with a statin? Diabetes Care 32 Suppl. 2 2009 S378 S383
8. L. Golan, J.D. Birkmeyer, H.G. Welch The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors Ann Intern Med 131 1999 660 667 (Pubitemid 29517951)
9. R. Balkrishnan, R. Rajagopalan, F.T. Camacho Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study Clin Ther 25 2003 2958 2971 (Pubitemid 37510603)
10. M. Brandle, M.B. Davidson, D.L. Schriger Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes Diabetes Care 26 2003 1796 1801 (Pubitemid 36929122)
11. K.L. Hepke, M.T. Martus, D.A. Share Costs and utilization associated with pharmaceutical adherence in a diabetic population Am J Manag Care 10 2004 144 151 (Pubitemid 38332389)
12. T.P. Gilmer, P.J. O'Connor, W.A. Rush Predictors of health care costs in adults with diabetes Diabetes Care 28 2005 59 64 (Pubitemid 40095783)
13. A.B. Rosen, M.B. Hamel, M.C. Weinstein Cost-effectiveness of full Medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes Ann Intern Med 143 2005 89 99
14. M.C. Sokol, K.A. McGuigan, R.R. Verbrugge, R.S. Epstein Impact of medication adherence on hospitalization risk and healthcare cost Med Care 43 2005 521 530 (Pubitemid 40847288)
15. B.C. Stuart, L. Simoni-Wastila, L. Zhao Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings Diabetes Care 32 2009 647 649
16. B. Stuart, A. Davidoff, R. Lopert Does medication adherence lower Medicare spending among beneficiaries with diabetes? Health Serv Res 46 2011 1180 1199
17. D.P. Goldman, G.F. Joyce, Y. Zheng Prescription drug cost sharing: associations with medication and medical utilization and spending and health JAMA 298 2007 61 69 (Pubitemid 47026771)
18. B.H. Gilman, J. Kautter Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries Health Serv Res 43 2008 478 495 (Pubitemid 351442581)
19. H.A. Huskamp, P.A. Deverka, A.M. Epstein The effect of incentive-based formularies on prescription-drug utilization and spending N Engl J Med 349 2003 2224 2232 (Pubitemid 37485139)
20. D.P. Goldman, G.F. Joyce, J.J. Escarce Pharmacy benefits and the use of drugs by the chronically ill JAMA 291 2004 2344 2350 (Pubitemid 38656301)
21. T.B. Gibson, T.L. Mark, K.A. McGuigan The effects of prescription drug copayments on statin adherence Am J Manag Care 12 2006 509 517 (Pubitemid 44412033)
22. D.P. Goldman, G.F. Joyce, J.J. Escarce Pharmacy benefits and the use of drugs by the chronically ill JAMA 291 2004 2344 2350 (Pubitemid 38656301)
23. T.B. Gibson, T.L. Mark, K.A. McGuigan The effects of prescription drug copayments on statin adherence Am J Manag Care 12 2006 509 517 (Pubitemid 44412033)
24. M. Chernew, T.B. Gibson, K. Yu-Isenberg Effects of increased patient cost sharing on socioeconomic disparities in health care J Gen Intern Med 23 2008 1131 1136
25. A.B. Rosen, M.B. Hamel, M.C. Weinstein Cost-effectiveness of full Medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes Ann Intern Med 143 2005 89 99
26. J.J. Mahoney Lowering patient drug acquisition costs to improve health outcomes and costs Manag Care Interface 19 2006 13
27. F. Zeng, J.J. An, R. Scully The impact of value-based benefit design on adherence to diabetes medications: a propensity score-weighted difference in difference evaluation Value Health 13 2010 846 852
28. N.K. Choudhry, M.A. Fischer, J. Avorn At Pitney Bowes, value-based insurance design cut copayments and increased drug adherence Health Aff (Millwood) 29 2010 1995 2001
29. M.L. Maciejewski, J.F. Farley, J. Parker, D. Wansink Copayment reductions generate greater medication adherence in targeted patients Health Aff (Millwood) 29 2010 2002 2008
30. A. Spaulding, A.M. Fendrick, W.H. Herman A controlled trial of value-based insurance design - the MHealthy: Focus on Diabetes (FOD) trial Implement Sci 4 2009 19
31. N.K. Choudhry, T. Brennan, M. Toscano Rationale and design of the post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies Am Heart J 156 2008 31 36
32. Centers for Medicare & Medicaid Services Medicare Current Beneficiary Survey http://www.cms.gov/mcbs/ [Accessed December 14, 2009]
33. Buccaneer Computer Systems and Services, Inc Chronic Condition Warehouse user manual http://ccwdata.org/downloads/CCW%20User%20Manual.pdf [Accessed June 15, 2009]
34. P.L. Hebert, L.S. Geiss, E.F. Tierney Identifying persons with diabetes using Medicare claims data Am J Med Qual 14 1999 270 277
35. S.H. Saydah, L.S. Geiss, E. Tierney Review of the performance of methods to identify diabetes cases among vital statistics, administrative, and survey data Ann Epidemiol 14 2004 507 516 (Pubitemid 39061162)
36. U.S. Department of Labor, Bureau of Labor Statistics Consumer price index: all urban consumers www.bls.gov/cpi [Accessed June 15, 2009]
37. R.B.S. D'Agostino, R.S. Vasan, M.J. Pencina General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 2008 743 753 (Pubitemid 351640675)
38. W.E. Encinosa Value-based insurance design in Medicare Appl Health Econ Health Pol 7 2009 149 154
39. L. Murphy, J. Carloss, R.E. Brown Value-based insurance design in the Medicare prescription drug benefit/an analysis of policy options http://www.avalerehealth.net/research/docs/Value-Based-Insurance-Design-in-the- Medicare-Prescription-Drug-Benefit.pdf [Accessed March 8, 2011]
40. E.S. Huang, A. Basu, M. O'Grady, J.C. Capretta Projecting the future diabetes population size and related costs for the U.S. Diabetes Care 32 2009 2225 2229
41. R.E. Aubert, J. Yao, F. Xia, S.B. Garavaglia Is there a relationship between early statin compliance and a reduction in healthcare utilization? Am J Manag Care 16 2010 459 466
42. S.I. McFarlane, R. Muniyappa, R. Francisco, J.R. Sowers Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond J Clin Endocrinol Metab 87 2002 1451 1458 (Pubitemid 34615220)
43. J. Davignon Beneficial cardiovascular pleiotropic effects of statins Circulation 109 2004 III39 III43
44. S. Nicholson The effect of cost sharing on employees with diabetes Am J Manag Care 12 2006 Spec no.:SP20-6
45. S.D. Pearson, P.B. Bach How Medicare could use comparative effectiveness research in deciding on new coverage and reimbursement Health Aff (Millwood) 29 2010 1796 1804
46. A.M. Fendrick, D.G. Smith, M.E. Chernew Applying value-based insurance design to low-value health services Health Aff (Millwood) 29 2010 2017 2021
47. P.J. Neumann, H.R. Auerbach, J.T. Cohen, D. Greenberg Low-value services in value-based insurance design Am J Manag Care 16 2010 280 286